Technology
DNA X, Inc.(SONM)
Live Price
Offline$4.74
+0.85% today
1Y Change
-79.27%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- $10.00M
- Revenue Growth
- -100.0%
- EPS Growth
- -300.8%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
DNA X, Inc. (SONM) is a Technology stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $4.74 and down 79.3% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of -300.8%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS -300.8%, free cash flow -170.4% with operating margin 0.0% and ROIC -488.3%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SONM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-100.0% vs +11.9% peer median
Operating Margin
Below sector median
0.0% vs +22.0% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 20, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -100.0% and EPS is at -300.8%, with operating margin around 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.6% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 20, 2026 | โ | -12.1% | -5.4% | โ |
2026 Jan 30, 2026 | โ | +0.9% | +5.3% | -3.7% |
2025 Oct 31, 2025 | -171.5% | -1.2% | -1.7% | -52.6% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SONM
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SONM Max Drawdown
-91.32%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SONM and SPY.
Company Overview
DNA X, Inc.
NASDAQ Capital Market
DNA X, Inc. provides enterprise 5G solutions in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers ruggedized cell phones for task workers, which include Sonim XP10, Sonim XP5plus, Sonim XP3plus, and Sonim XP Pro; XP100 4G and XP400 5G professional rugged phones; XP Pro 5G rugged smartphones; and XP3plus 5G rugged flip phones. It also provides connected solutions comprising fixed wireless access and mobile hotspot devices, such as Sonim H100 low- and mid-range mobile hotspots; Sonim H700; and Sonim H500-series of 5G mobile hotspots. In addition, the company offers SonimWare software and industrial-grade accessories. It sells its products through wireless carriers, distributors of data devices, communications system integrators, and electronics resellers. The company serves the transportation and logistics, construction, manufacturing, facilities management, energy and utility, mining, federal government, and public safety sectors. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
- Leadership
- Michael C. Mulica
- IPO Date
- May 10, 2019
- Employees
- 160
- Street Address
- 4445 Eastgate Mall
- Mailing
- San Diego, CA, 92121
- Region
- San Diego, CA, US
- Reporting Currency
- USD
- Investor Line
- 650 378 8100
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- -100.0%
- EPS
- -300.8%
- Free Cash Flow
- -170.4%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 839.6%
- ROIC
- -488.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.60
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.